For: | Suzuki H, Sato K, Takagi H, Kanda D, Sohara N, Kakizaki S, Nakajima H, Otsuka T, Nagamine T, Mori M. Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2. World J Gastroenterol 2006; 12(6): 945-950 [PMID: 16521225 DOI: 10.3748/wjg.v12.i6.945] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i6/945.htm |
Number | Citing Articles |
1 |
Seyed-Moayed Alavian, Bita Behnava, Seyed Vahid Tabatabaei. Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 2010; 66(11): 1071 doi: 10.1007/s00228-010-0881-7
|
2 |
Ashwani K. Singal, Sarat C. Jampana, Steven A. Weinman. Antioxidants as therapeutic agents for liver disease. Liver International 2011; 31(10): 1432 doi: 10.1111/j.1478-3231.2011.02604.x
|
3 |
Ronald L. Koretz. Advanced Nutrition and Dietetics in Nutrition Support. 2018; : 313 doi: 10.1002/9781118993880.ch5.11
|
4 |
Jin Hwi Kim, Seog Nyeon Bae, Chung Won Lee, Min Jong Song, Sung Jong Lee, Joo Hee Yoon, Keun Ho Lee, Soo Young Hur, Tae Chul Park, Jong Sup Park. A pilot study to investigate the treatment of cervical human papillomavirus infection with zinc-citrate compound (CIZAR®). Gynecologic Oncology 2011; 122(2): 303 doi: 10.1016/j.ygyno.2011.04.026
|
5 |
Takeaki Nagamine, Ken Sato, Satoru Kakizaki, Takahiro Satoh, Masashi Koka, Tomihiro Kamiya. Analysis of Erythrocyte Elements in Chronic Hepatitis C Patients Receiving PegIFN Monotherapy, Dual Therapy, and Triple Therapy using in-air MicroPIXE. The KITAKANTO Medical Journal 2016; 66(2): 91 doi: 10.2974/kmj.66.91
|